Literature DB >> 15722664

Outcomes and prognostic factors of systolic as compared with diastolic heart failure in urban America.

Peter A McCullough1, Akshay K Khandelwal, John E McKinnon, Heather J Shenkman, Vijayamalini Pampati, David Nori, Roberta A Sullivan, Keisha R Sandberg, Scott Kaatz.   

Abstract

We sought to describe a large heart failure (HF) population with respect to systolic and diastolic abnormalities in terms of demographics, echocardiographic parameters, and survival. Using data abstracted from the Resource Utilization Among Congestive Heart Failure (REACH) study, a targeted subpopulation of 3471 patients had electrocardiographic, echocardiographic, and clinical data taken from automated sources during the first year of diagnosis. Among the HF population, 1811 (52.2%) had diastolic HF. Prevalence of diastolic HF trended with age, from 46.4% in those less than 45 years to 58.7% in those 85 years or older (p=0.001 for trend). Patients with diastolic HF had a higher mean ejection fraction (55.7% vs. 28.0%), lower left ventricular end-systolic diameter (3.11 vs. 4.74 cm), and lower left atrium:aortic outlet ratio (1.28 vs. 1.38) (p=0.001 for each comparison). Annualized age, sex, and race-adjusted mortality were 11.2% and 13.0% for those with diastolic and systolic HF, respectively (p=0.001). In a large, racially mixed, urban HF population, those with diastolic HF predominate and enjoy better-adjusted survival than counterparts with systolic HF.

Entities:  

Mesh:

Year:  2005        PMID: 15722664     DOI: 10.1111/j.1527-5299.2005.03731.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  10 in total

Review 1.  Aging and heart failure: changing demographics and implications for therapy in the elderly.

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

Review 2.  STEMI and heart failure in the elderly: role of adverse remodeling.

Authors:  Anwar Jelani; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

3.  E/A ratio alone cannot reliably diagnose diastolic dysfunction in the assessment before and after TIPS.

Authors:  R D Abeles; D L Shawcross; G Auzinger
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

Review 4.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Ken Kaila; Mark J Haykowsky; Richard B Thompson; D Ian Paterson
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

5.  [Epidemiology and prognosis of heart failure].

Authors:  F Edelmann
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

Review 6.  Calcium mishandling in diastolic dysfunction: mechanisms and potential therapies.

Authors:  Michelle L Asp; Joshua J Martindale; Frazer I Heinis; Wang Wang; Joseph M Metzger
Journal:  Biochim Biophys Acta       Date:  2012-09-27

7.  Mitral annular velocity measurement with cardiac magnetic resonance imaging using a novel annular tracking algorithm: Validation against echocardiography.

Authors:  Paaladinesh Thavendiranathan; Christoph Guetter; Juliana Serafim da Silveira; Xiaoguang Lu; Debbie Scandling; Hui Xue; Marie-Pierre Jolly; Subha V Raman; Orlando P Simonetti
Journal:  Magn Reson Imaging       Date:  2018-08-31       Impact factor: 2.546

8.  Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction.

Authors:  Natalie A Bello; Brian Claggett; Akshay S Desai; John J V McMurray; Christopher B Granger; Salim Yusuf; Karl Swedberg; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2014-05-29       Impact factor: 8.790

Review 9.  Role of angiotensin II in the evolution of diastolic heart failure.

Authors:  Kavitha M Chinnaiyan; Daniel Alexander; Peter A McCullough
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-12       Impact factor: 3.738

10.  Cardiorenal syndrome caused by heart failure with preserved ejection fraction.

Authors:  Chiara Lazzeri; Serafina Valente; Roberto Tarquini; Gian Franco Gensini
Journal:  Int J Nephrol       Date:  2011-02-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.